Atlas Trials

Telotristat With Lutathera in Neuroendocrine Tumors

Clinical trial NCT04543955 · TERMINATED

Trial details

NCT number
NCT04543955
Sponsor
Lowell Anthony, MD
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2021-09-13
Primary completion
2022-06-03
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.